Cargando…

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?

CONTEXT: Platelet-rich plasma (PRP) may affect soft tissue healing via growth factors released after platelet degranulation. Because of this potential benefit, clinicians have begun to inject PRP for the treatment of tendon, ligament, muscle, and cartilage injuries and early osteoarthritis. EVIDENCE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cole, Brian J., Seroyer, Shane T., Filardo, Giuseppe, Bajaj, Sarvottam, Fortier, Lisa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2010
Materias:	Primary Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445108/ https://www.ncbi.nlm.nih.gov/pubmed/23015939 http://dx.doi.org/10.1177/1941738110366385

Ejemplares similares

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Yellow fever control in Cameroon: Where are we now and where are we going?
por: Wiysonge, Charles Shey, et al.
Publicado: (2008)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Structure functions and the EMC effect: where are we now and where are we going to?
por: Wimpenny, S J
Publicado: (1984)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
por: Mauro, Aurelio, et al.
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Comment on: Breast Implant Surfaces and Their Impact on Current Practices: Where Are We Now and Where Are We Going
por: Nava, Maurizio Bruno, et al.
Publicado: (2020)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019)

Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?
por: Giri, Paresh C., et al.
Publicado: (2021)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
por: Mesnier, Jules, et al.
Publicado: (2022)

A personal view on basic education in reproduction: Where are we now and where are we going?
por: Jonker, F. Herman
Publicado: (2020)

Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
por: Mazzitelli, Carlotta, et al.
Publicado: (2023)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Where are we now?
Publicado: (1977)

Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?
por: Osman, Khalid A, et al.
Publicado: (2006)

Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016)

Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?
por: Buttgereit, Frank, et al.
Publicado: (2015)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bsapmlgoqkt7hobitjprdtd3bc